These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Foscarnet for cytomegalovirus pneumonitis. Apperley JF; Marcus RE; Goldman JM; Wardle DG; Gravett PJ; Chanas A Lancet; 1985 May; 1(8438):1151. PubMed ID: 2860348 [No Abstract] [Full Text] [Related]
29. Foscarnet (phosphonoformate sodium) in the treatment of recurrent male genital herpes. Lim KB; Doraisingham S; Thirumoorthy T; Lee CT; Ling AE; Tan T Ann Acad Med Singap; 1986 Oct; 15(4):617-22. PubMed ID: 2952046 [TBL] [Abstract][Full Text] [Related]
30. [Fulminant hepatitis in a heroin addict caused by coinfection by B and delta viruses]. Rodríguez M; García R; Pérez R; Rodrigo L Med Clin (Barc); 1985 Oct; 85(11):474. PubMed ID: 4068818 [No Abstract] [Full Text] [Related]
31. Clinical course of recurrent genital herpes and treatment with foscarnet cream: results of a Canadian multicenter trial. Sacks SL; Portnoy J; Lawee D; Schlech W; Aoki FY; Tyrrell DL; Poisson M; Bright C; Kaluski J J Infect Dis; 1987 Feb; 155(2):178-86. PubMed ID: 2949023 [TBL] [Abstract][Full Text] [Related]
32. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011]. Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641 [No Abstract] [Full Text] [Related]
35. [Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet]. Rogeaux O; Bedos JP; Wolf M; Vachon F Ann Med Interne (Paris); 1992; 143(3):219-20. PubMed ID: 1326248 [No Abstract] [Full Text] [Related]
36. Fulminant hepatitis B and delta virus coinfection in AIDS. Lichtenstein DR; Makadon HJ; Chopra S Am J Gastroenterol; 1992 Nov; 87(11):1643-7. PubMed ID: 1442692 [No Abstract] [Full Text] [Related]
37. First report of successful clearance of hepatitis B and D coinfection with tenofovir monotherapy. James G; Sidhu P; Raza M Hepatology; 2015 Jul; 62(1):317-8. PubMed ID: 25234819 [No Abstract] [Full Text] [Related]
38. Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients. Ringdén O; Lönnqvist B; Paulin T; Ahlmén J; Klintmalm G; Wahren B; Lernestedt JO J Antimicrob Chemother; 1986 Mar; 17(3):373-87. PubMed ID: 3009383 [TBL] [Abstract][Full Text] [Related]